Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-26-005205
Filing Date
2026-08-14
Accepted
2026-08-14 08:34:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8998
  Complete submission text file 0000919574-26-005205.txt   10721
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Subject) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91961 | Film No.: 261276437
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1674 MERIDIAN AVENUE SUITE 320 MIAMI BEACH FL 33139
Business Address 1674 MERIDIAN AVENUE SUITE 320 MIAMI BEACH FL 33139 845-239-2521
Sirenia Capital Management LP (Filed by) CIK: 0002115022 (see all company filings)

EIN.: 395013488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A